Page-13 of COVID-19

Covid: WHO recommends 3rd dose for immunocompromised

The World Health Organisation (WHO) has recommended for third dose of immunocompromised, following a four-day meeting of the “Strategic Advisory Group of Experts (SAGE) on Immunization”.  The final report on the matter will be issued in December. Key Points According ..

Month: 

Guidelines for PM-CARES for Children scheme

Ministry of Women and Child Development issued a detailed guidelines for “PM CARES for Children Scheme” on October 7, 2021. Background Guidelines were issued in the backdrop of announcement made by Prime Minister Narendra Modi on May 29, 2021 regarding ..

Month: 

Health Minister releases ‘The State of the World’s Children 2021’

Union Health Minister, Mansukh Mandaviya, released a report titled “The State of the World’s Children 2021: On My Mind: promoting, protecting and caring for children’s mental health” on October 5, 2021 in New Delhi. The state of World’s Children 2021 ..

Month: 

EU approves Pfizer-BioNTech COVID vaccine booster

European Medicines Agency (EMA) approved the booster doses of Pfizer/BioNTech Covid-19 vaccine for people aged 18 and above on October 4, 2021. Key Facts This approval given as data for the vaccine showed a rise in antibody levels when a ..

Month: 

2021 Nobel Prize in Medicine

On October 4, 2021, American scientists David Julius and Ardem Patapoutian won the prestigious “2021 Nobel Prize for Medicine”. Key Facts They won the prize for their discoveries of receptors for temperature and touch. According to award-giving body, these discoveries ..

Month: 

Molnupiravir: New drug to treat COVID-19

On October 1, 2021, Pharmaceutical company “Merck and Ridgeback Biotherapeutics” announced the early results of Phase-3 trials of its anti-viral drug called molnupiravir. As per the results, Molnupiravir has reduced the chances of hospitalisation by half among COVID-19 patients with ..

Month: 

‘Bal Raksha Kit’- Things to Know

All India Institute of Ayurveda (AIIA), under the AYUSH ministry, has developed “Bal Raksha Kit” which is an immunity boosting kit. Key Points This kit was developed keeping the third wave of the coronavirus disease in mind. This is an ..

Month: 

Pfizer starts study of mRNA Flu vaccine

On September 28, 2021, Pfizer Inc. announced that the first batch of participants have been dosed with the single dose quadrivalent mRNA vaccine in a Phase 1 clinical trial. Highlights Under the phase 1 trial, safety, tolerability, and immunogenicity of ..

Month: